9 July 2026
Linklaters advises BNP Paribas, Deutsche Bank and J.P. Morgan on bridge loan financing for Merck KGaA
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Marc Trinkaus Lead | Linklaters | Partner | Banking | Frankfurt |
| Urs Lewens Lead | Linklaters | Counsel | Banking | Frankfurt |
| Gregory Gewirtz | Linklaters | Partner | Corporate M&A | New York |
| Philip Lee | Linklaters | Partner | Banking | New York |
| Michelle Lo | Linklaters | Partner | Tax | New York |
| Ulrich Johann | Linklaters | Counsel | Tax | Frankfurt |
| Omer Harel | Linklaters | Counsel | Tax | Not stated |
| David Mba | Linklaters | Senior associate | Corporate M&A | New York |
| Reuven Rosen | Linklaters | Senior associate | Tax | New York |
| Alexandra Selezneva | Linklaters | Other | Banking | Düsseldorf |
| Matthias Horváth | Linklaters | Associate | Banking | Frankfurt |
| Benedikt Kruse | Linklaters | Associate | Tax | Frankfurt |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 11.3bn (approximately US$11.3bn)
- What the figure measures
- Enterprise value
- Client
- BNP Paribas, Deutsche Bank and J.P. MorganLenders
- Counterparties
- Merck KGaA (Borrower)
Bio-Techne Corporation (Target)